Open AccessRipretinib (Qinlock)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.428
Subject(s) - regorafenib , reimbursement , sunitinib , medicine , imatinib , gist , drug , family medicine , intensive care medicine , pharmacology , stromal cell , political science , cancer , colorectal cancer , health care , myeloid leukemia , law